Metastatic Urothelial Cancer Recruiting Phase 1 / 2 Trials for Sacituzumab govitecan (DB12893)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0066157 (Metastatic Urothelial Cancer) | Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05101096 | Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors | Treatment |